News from BPS

New series on Manufacturing Economics

Biopharm Software Solutions is proud to announce the advent of a new series on Manufacturing Economics 'Delivering Affordable Biologics from Gene to Vial' to be published in Bioprocess International. This series will be led by two established industry figures in the field of the economics of developing and manufacturing biopharmaceuticals, Andrew Sinclair and Miriam Monge.

The series will invite contributions from leading figures to co author relevant and topical issues facing the industry. The first article in the series Economic challenges for Manufacturing Biologics in the new millennium' published in the March edition of Bioprocess International received top ratings as one of the most read articles of the month demonstrating the importance that the industry is now giving to this theme.

Look out for the next article 'Measuring Manufacturing Costs and its Impact on Organizations' in the May issue of Bioprocess International featuring an interview with process development expert Richard Francis.


Rapid Production of Swine Flu H1 Hemagglutinin

Xcellerex, Pfenex Inc, Biopharm Services and Collaborators Complete Successful Test for Rapid Production of Swine Flu H1 Hemagglutinin. More here >

Career opening

Biopharm Services recruits Consultant Engineer. See the Careers page.

CLIENT FEEDBACK

Click on logo for feedback

Biopharm Software Services

Promedior Inc Feedback

'BioSolve is an excellent tool for planning early stage process development alternatives.'

'BioSolve provides a quantitative edge when presenting proposed directions to investors.'

'BioSolve enables us to focus on potential process bottlenecks in terms of cost or throughput.'

Scott Willett, Director biopharmaceutical development, Promedior Inc

Dow Pharmaceuticals Feedback

'One hidden benefit of BioSolve is that it is comes populated with an enormous wealth of historical industry data and this allows us to benchmark Pfēnex Expression Technology's performance more accurately than we would be able to do with internal data alone.

'This enables us to better articulate the key Cost of Goods advantages realized by our clients'

Patrick Lucy, Global Business Development Leader, Pfēnex Inc, Dow Pharmaceuticals

Xcellerex Inc Feedback

'BioSolve has been a very useful tool for demonstrating to our prospective customers the benefit of disposables and the FlexFactory platform.'

'One hidden benefit of BioSolve is that it is comes populated with an enormous wealth of historical industry data and this allows us to benchmark more accurately than we would be able to do with internal data alone.'

'We use BioSolve with prospective customers to plug their specific numbers into the model. All the data and assumptions are clearly presented for review and discussion. The Excel format and preset templates allows BioSolve to be reconfigured quickly and easily at a high level or manipulated at a very detailed level, depending upon the needs and sophistication of the user.'

Geoff Hodge, Managing Director - Technology, Xcellerex Inc.

Sanofi Pasteur Feedback

'Validating investment scenarios is a key part of developing our business strategy and is used to set priorities. With BioSolve, what used to take months now can be evaluated in a day! We were amazed recently when on a particular case we were able to generate comparable and coherent results in a day that did take us months manually to prepare. Not only does this save a lot of time it helps us to carry out sensitivity and 'what if' scenario analyses with BioSolve, this supports better informed decision making.'

Jean-Marc Guillaume, Head of cell culture and virology, Sanofi Pasteur vaccines

Avecia Biologics Feedback

'BPS models provide Insight into the complexities of biotech plants, It helps to set Direction in projects and improvement programmes'

Bruce Williams Avecia Biologics

Millipore Feedback

'It is important for the customer to select the right mix of Mobius® single-use solutions to optimize their manufacturing process and maximize the return on investment. BioSolve, an industry wide popular modeling package allows the customers to map their process and develop cost of ownership models'.

Vikas Gupta, Group Product Manager, Advanced Manufacturing Solutions, Millipore corporation

BioSim - Evaluate change dynamically in your new or existing facility before it happens

BioSim are custom models based on a modular template that we build and deliver to you:

  • Built in 6 to 8 weeks
  • Addressing your specific requirements
  • Delivered to you for your use - you can add equipment, change workflows and manage multiple processes.
  • We provide support and training tailored to your needs

Have you ever wondered what the real capacity of your facility is for multi-product manufacture? What about the implications of a new process, or process change? How would you go about optimising capital for a new build? BioSim has been answering these questions and others for more than ten years. It also provides insight into lean manufacturing by:

  • Evaluating shift patterns and labour demand to evaluate the best personnel strategies for your facility
  • Understanding storage area and WIP constraints
  • Streamlining waste through elimination of wasteful activities

All this can be evaluated on the computer dynamically for your facility, working to your constraints before change happens. BioSim has been used in the biopharm, vaccines, fill finish and diagnostics industries. We can represent the workflows and business processes that define your operations, and have successfully modelled laboratory, QC, pilot and small & large manufacturing operations. See how our customers use BioSim to:

  • Streamline operations and implement Operational Excellence
  • Minimise utility infrastructure in a new build
  • Evaluate and define rapid response facilities